Submission for OMB Review; 30-Day Comment Request; Post-Award Reporting Requirements Including Research Performance Progress Report Collection (Office of the Director), 77872-77874 [2024-21802]
Download as PDF
<![CDATA[
77872
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Form name
Type of respondent
Data Management and Sharing Plan ...................
VCOC Certification ...............................................
SBIR/STTR Funding Agreement Certification ......
Grant Applicant .............
Grant Applicant .............
Grant Applicant .............
Number of
responses per
respondent
73,117
6
1,500
Average
burden per
response
(in hours)
Total annual
burden hours
1
1
1
2
5/60
15/60
146,234
1
375
PHS Fellowship—Electronic
PHS Fellowship Supplemental Form (includes F
reference letters).
Biosketch (Fellowship) ..........................................
416–1 ....................................................................
PHS 416–5 ...........................................................
PHS 6031 .............................................................
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Grant Appli-
6,707
1
13
87,191
Grant Appli-
6,707
1
2
13,414
Grant Appli-
29
1
10
290
Grant Appli-
6,707
1
5/60
559
Grant Appli-
6,217
1
5/60
518
239
1
11
2,629
486,749
486,749
........................
2,175,670
NIH Other Transaction
NIH Other Transaction Application Form .............
Total ...............................................................
Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21801 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Cystic Fibrosis
Research and Translation Centers.
Date: October 31–November 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Other Transaction Applicant.
.......................................
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707
Democracy Boulevard, Rm 7015, Bethesda,
MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21739 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Post-Award
Reporting Requirements Including
Research Performance Progress
Report Collection (Office of the
Director)
AGENCY:
National Institutes of Health,
HHS.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Mikia P. Currie, Program
Analyst, Office of Policy for Extramural
Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda,
Maryland 20892, or call a non-toll-free
number 301–435–0941 or email your
request, including your address to
ProjectClearanceBranch@mail.nih.gov.
Formal requests for additional plans and
SUMMARY:
E:\FR\FM\24SEN1.SGM
24SEN1
77873
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
instruments must be requested in
writing.
This
proposed information collection was
previously published in the Federal
Register on May 22, 2024, pages 45000–
45001 (89 FR 45000) and allowed 60
days for comment. One public comment
was received. The purpose of this notice
is to allow an additional 30 days for
public comment.
The Office of the Director (OD), Office
of Extramural Research (OER), National
Institutes of Health (NIH), may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid Office of Management
and Budget (OMB) control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection Title: Public
Health Service (PHS) Post-award
Reporting Requirements Revision, OMB
0925–0002, Expiration Date 01/31/2026,
Office of the Director (OD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: Starting in Fiscal Year 2025,
NIH will require applicable recipients to
address progress in association with
their approved Data Management and
Sharing (DMS) Plans within the
Research Performance Progress Report
SUPPLEMENTARY INFORMATION:
(RPPR) in accordance with the final NIH
Policy for Data Management and
Sharing (DMS Policy) to promote the
management and sharing of scientific
data generated from NIH-funded or
conducted research. The progress report
forms will be updated to align with this
requirement. The Training Data Tables
will also be updated to reduce burden
and promote consistent information
collection, including limiting the scope
of information collection to data only
relevant to the training stage(s) of the
proposed program in table 1 and
removing instructions in table 8 that are
reported within the RPPR. Effective for
May 2025, NIH will be adopting the
Common Forms for Biographical Sketch
and Current and Pending (Other)
Support as part of the directive from
Guidance for Implementing National
Security Presidential Memorandum-33.
The Common Forms are part of a
separate OMB collection, currently
approved under 3145–0279 (Expiration
Date 10/31/2026). As such, elements
that will be collected within the
Common Forms will be removed from
NIH’s current NIH Biosketch and Other
Support formats. NIH will continue to
collect additional information not
captured on the Common Forms to
adhere to the agency’s implementation
of the NIH Peer Review Regulations at
42 CFR part 52 as part of the NIH
Biosketch form, which will be renamed
the NIH Biographical Sketch
Supplement to reflect the supplemental
information requested. The application
and progress report forms and
associated instructions will be updated
to align with these new requirements.
The RPPR is required to be used by all
NIH, Food and Drug Administration,
Centers for Disease Control and
Prevention, and Agency for Healthcare
Research and Quality recipients. Interim
progress reports are required to continue
support of a PHS grant for each budget
year within a competitive segment. This
collection also includes other PHS postaward reporting requirements: PHS
416–7 National Research Service Award
(NRSA) Termination Notice, PHS 2271
Statement of Appointment, 6031–1
NRSA Annual Payback Activities
Certification, Department of Health and
Human Services (HHS) 568 Final
Invention Statement and Certification,
and PHS 3734 Statement Relinquishing
Interests and Rights in a PHS Research
Grant. The PHS 416–7, 2271, and 6031–
1 is used by NRSA recipients to activate,
terminate, and provide for payback of a
NRSA. Closeout of an award requires a
Final Invention Statement (HHS 568)
and Final Progress Report. The PHS
3734 serves as the official record of
recipient relinquishment of a PHS
award when an award is transferred
from one recipient institution to
another. Pre-award reporting
requirements are simultaneously
consolidated under 0925–0001 and the
changes to the collection here are
related.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
629,463.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Number of
respondents
Type of respondent
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
lotter on DSK11XQN23PROD with NOTICES1
Reporting
PHS 416–7 ...........................................................
PHS 6031–1 .........................................................
PHS 568 ...............................................................
PHS 2271 .............................................................
PHS 2590 .............................................................
RPPR—Core Data ................................................
Biosketch (Part of RPPR) .....................................
Data Tables (Part of RPPR) .................................
Trainee Diversity Report (Part of RPPR) .............
PHS Human Subjects and Clinical Trial Information.
Publication Reporting ............................................
Final RPPR—Core Data .......................................
Data Tables (Part of Final RPPR) ........................
Trainee Diversity Report (Part of Final RPPR) ....
PHS Human Subjects and Clinical Trial Information (Part of Final RPPR).
PHS 3734 .............................................................
Data Management and Sharing Plan (Part of
RPPR).
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
12,580
1,778
11,180
22,035
243
32,098
2,544
758
480
6,420
1
1
1
1
1
1
1
1
1
1
30/60
20/60
5/60
15/60
18
9
2
4
15/60
3
6,290
593
932
5,509
4,374
288,882
5,088
3,032
120
25,680
Recipient
Recipient
Recipient
Recipient
Recipient
.......................
.......................
.......................
.......................
.......................
97,023
18,000
758
480
3,600
3
1
1
1
1
5/60
11
4
15/60
4
24,256
198,000
3,032
120
14,400
Recipient .......................
Recipient .......................
479
15,649
1
1
30/60
2
240
31,298
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\24SEN1.SGM
24SEN1
77874
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total annual
burden hours
Form name
Type of respondent
Data Management and Sharing Plan (Part of
Final RPPR).
Recipient .......................
8,621
1
2
17,242
Reporting Burden Total .................................
.......................................
........................
........................
........................
629,088
Recording Keeping
SBIR/STTR Life Cycle Certification ......................
Recipient .......................
1,500
1
15/60
375
Grand Total ....................................................
.......................................
236,226
430,272
........................
629,463
Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21802 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: October 18, 2024.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC)
Leadership Announcements, CC CEO Update
of Recent Activities and Organizational
Priorities, Status Report on Key CC Strategic
Plan Initiatives, and Other Business of the
Clinical Center Research Hospital Board
(CCRHB).
Place: National Institutes of Health,
Building 31, Conference Room 6C02 A & B,
9000 Rockville Pike, Bethesda, MD 20892 (InPerson and Virtual)
Contact Persons:
Patricia Piringer, RN, MSN (C), National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892 ppiringer@
cc.nih.gov, (301) 402–2435, (202) 460–7542
(direct).
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Natascha Pointer, Management Analyst,
Executive Assistant to Dr. Gilman Office of
the Chief Executive Officer, National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892, npointer@
cc.nih.gov, (301) 496–4114, (301) 402–2434
(direct).
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person(s) listed
on this notice. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the CCRHB
website: https://www.ccrhb.od.nih.gov/
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21838 Filed 9–23–24; 8:45 am]
[FR Doc. 2024–21738 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Palliative
Care Research Consortium.
Date: November 7, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Janetta Lun, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institutes of Health, 5601
Fishers Lane, Rm. 213, Rockville, MD 20814,
(301) 496–9666, janetta.lun@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Pages 77872-77874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Post-Award
Reporting Requirements Including Research Performance Progress Report
Collection (Office of the Director)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Ms. Mikia P.
Currie, Program Analyst, Office of Policy for Extramural Research
Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland
20892, or call a non-toll-free number 301-435-0941 or email your
request, including your address to [email protected].
Formal requests for additional plans and
[[Page 77873]]
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on May 22, 2024, pages
45000-45001 (89 FR 45000) and allowed 60 days for comment. One public
comment was received. The purpose of this notice is to allow an
additional 30 days for public comment.
The Office of the Director (OD), Office of Extramural Research
(OER), National Institutes of Health (NIH), may not conduct or sponsor,
and the respondent is not required to respond to, an information
collection that has been extended, revised, or implemented on or after
October 1, 1995, unless it displays a currently valid Office of
Management and Budget (OMB) control number.
In compliance with section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, NIH has submitted to OMB a request for review and approval
of the information collection listed below.
Proposed Collection Title: Public Health Service (PHS) Post-award
Reporting Requirements Revision, OMB 0925-0002, Expiration Date 01/31/
2026, Office of the Director (OD), National Institutes of Health (NIH).
Need and Use of Information Collection: Starting in Fiscal Year
2025, NIH will require applicable recipients to address progress in
association with their approved Data Management and Sharing (DMS) Plans
within the Research Performance Progress Report (RPPR) in accordance
with the final NIH Policy for Data Management and Sharing (DMS Policy)
to promote the management and sharing of scientific data generated from
NIH-funded or conducted research. The progress report forms will be
updated to align with this requirement. The Training Data Tables will
also be updated to reduce burden and promote consistent information
collection, including limiting the scope of information collection to
data only relevant to the training stage(s) of the proposed program in
table 1 and removing instructions in table 8 that are reported within
the RPPR. Effective for May 2025, NIH will be adopting the Common Forms
for Biographical Sketch and Current and Pending (Other) Support as part
of the directive from Guidance for Implementing National Security
Presidential Memorandum-33. The Common Forms are part of a separate OMB
collection, currently approved under 3145-0279 (Expiration Date 10/31/
2026). As such, elements that will be collected within the Common Forms
will be removed from NIH's current NIH Biosketch and Other Support
formats. NIH will continue to collect additional information not
captured on the Common Forms to adhere to the agency's implementation
of the NIH Peer Review Regulations at 42 CFR part 52 as part of the NIH
Biosketch form, which will be renamed the NIH Biographical Sketch
Supplement to reflect the supplemental information requested. The
application and progress report forms and associated instructions will
be updated to align with these new requirements. The RPPR is required
to be used by all NIH, Food and Drug Administration, Centers for
Disease Control and Prevention, and Agency for Healthcare Research and
Quality recipients. Interim progress reports are required to continue
support of a PHS grant for each budget year within a competitive
segment. This collection also includes other PHS post-award reporting
requirements: PHS 416-7 National Research Service Award (NRSA)
Termination Notice, PHS 2271 Statement of Appointment, 6031-1 NRSA
Annual Payback Activities Certification, Department of Health and Human
Services (HHS) 568 Final Invention Statement and Certification, and PHS
3734 Statement Relinquishing Interests and Rights in a PHS Research
Grant. The PHS 416-7, 2271, and 6031-1 is used by NRSA recipients to
activate, terminate, and provide for payback of a NRSA. Closeout of an
award requires a Final Invention Statement (HHS 568) and Final Progress
Report. The PHS 3734 serves as the official record of recipient
relinquishment of a PHS award when an award is transferred from one
recipient institution to another. Pre-award reporting requirements are
simultaneously consolidated under 0925-0001 and the changes to the
collection here are related.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 629,463.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Reporting
----------------------------------------------------------------------------------------------------------------
PHS 416-7..................... Recipient....... 12,580 1 30/60 6,290
PHS 6031-1.................... Recipient....... 1,778 1 20/60 593
PHS 568....................... Recipient....... 11,180 1 5/60 932
PHS 2271...................... Recipient....... 22,035 1 15/60 5,509
PHS 2590...................... Recipient....... 243 1 18 4,374
RPPR--Core Data............... Recipient....... 32,098 1 9 288,882
Biosketch (Part of RPPR)...... Recipient....... 2,544 1 2 5,088
Data Tables (Part of RPPR).... Recipient....... 758 1 4 3,032
Trainee Diversity Report (Part Recipient....... 480 1 15/60 120
of RPPR).
PHS Human Subjects and Recipient....... 6,420 1 3 25,680
Clinical Trial Information.
Publication Reporting......... Recipient....... 97,023 3 5/60 24,256
Final RPPR--Core Data......... Recipient....... 18,000 1 11 198,000
Data Tables (Part of Final Recipient....... 758 1 4 3,032
RPPR).
Trainee Diversity Report (Part Recipient....... 480 1 15/60 120
of Final RPPR).
PHS Human Subjects and Recipient....... 3,600 1 4 14,400
Clinical Trial Information
(Part of Final RPPR).
PHS 3734...................... Recipient....... 479 1 30/60 240
Data Management and Sharing Recipient....... 15,649 1 2 31,298
Plan (Part of RPPR).
[[Page 77874]]
Data Management and Sharing Recipient....... 8,621 1 2 17,242
Plan (Part of Final RPPR).
---------------------------------------------------------------
Reporting Burden Total.... ................ .............. .............. .............. 629,088
----------------------------------------------------------------------------------------------------------------
Recording Keeping
----------------------------------------------------------------------------------------------------------------
SBIR/STTR Life Cycle Recipient....... 1,500 1 15/60 375
Certification.
---------------------------------------------------------------------------------
Grand Total............... ................ 236,226 430,272 .............. 629,463
----------------------------------------------------------------------------------------------------------------
Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-21802 Filed 9-23-24; 8:45 am]
BILLING CODE 4140-01-P
